UnitedHealth Group Incorporated (UNH) continues to attract wide market interest, with several major funds and companies adjusting their stake in the company. Entities such as Kentucky Retirement Systems, Coastline Trust Co, and Natixis Advisors LLC have been quantifying their holdings, while analyst Jim Cramer maintains a bullish stance on UNH stock. Despite some underperformance in comparison to competitors on specific trading days, the company has still shown significant competitiveness in the market. The stock has seen a surge in Q3 and is considered one of the best low volatility stocks to invest in at the moment. Notably, the US government is trying to block UNH's $3.3 billion purchase of Amedisys. However, this has not deterred firms like CIBC Asset Management Inc and Oppenheimer Asset Management Inc from acquiring more shares. The company is expanding into Home Healthcare and Analytics and has been named Vantage Investment Partners LLC's largest position. UNH's alleged competition-curtailing conduct in its proposed dealings with Amedisys aside, the entity earns high marks from Goldman Sachs and has even witnessed an increase in stock value of 1.8%.
Unitedhealth Group Incorporated UNH News Analytics from Wed, 14 Aug 2024 02:42:50 GMT to Sat, 16 Nov 2024 20:11:29 GMT -
Rating 0
- Innovation 2
- Information 7
- Rumor 1
